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Objective. Cancer-related fatigue (CRF) is the most common and devastating problem in cancer patients even after successful
treatment. This study aimed to determine the effects of supervised multimodal exercise interventions on cancer-related fatigue
through a systematic review and meta-analysis. Design. A systematic review was conducted to determine the effectiveness of
multimodal exercise interventions onCRF.Databases of PubMed, CENTRAL, EMBASE, andOVIDwere searched between January
and March 2014 to retrieve randomized controlled trials. Risk of bias was evaluated using the PEDro scale. Results. Nine studies
(𝑛 = 772) were included in both systematic review and meta-analysis. Multimodal interventions including aerobic exercise,
resistance training, and stretching improved CRF symptoms (SMD = −0.23; 95% CI: −0.37 to −0.09; 𝑃 = 0.001).These effects were
also significant in patients undergoing chemotherapy (𝑃 < 0.0001). Nonsignificant differences were found for resistance training
interventions (𝑃 = 0.30). Slight evidence of publication bias was observed (𝑃 = 0.04).The studies had a low risk of bias (PEDro scale
mean score of 6.4 (standard deviation (SD) ± 1.0)). Conclusion. Supervised multimodal exercise interventions including aerobic,
resistance, and stretching exercises are effective in controlling CRF. These findings suggest that these exercise protocols should be
included as a crucial part of the rehabilitation programs for cancer survivors and patients during anticancer treatments.
1. Introduction
The number of people diagnosed with cancer worldwide has
been estimated to be as high as 10 million [1]. The respective
numbers with regard to cancer survivors may reach approx-
imately 25 million [1]. In Colombia, the National Cancer
Institute (NCI) declared that malignant tumors present the
third cause of mortality, increasing the mortality burden
during the last sixty decades from 6% to 15% in 2002
[2, 3]. Cancer-related fatigue (CRF) is a common problem
in cancer patients. Approximately, 80% to 100% of cancer
patients report suffering from CRF [4]. Furthermore, it has
been shown that patients continue to experience fatigue
symptoms for months or years after successful treatment
[4]. Several concepts of CRF have been published in the
biomedical literature. The National Comprehensive Cancer
Network (NCCN) [5] defined CRF as “a distressing, persis-
tent, subjective sense of physical, emotional and/or cognitive
tiredness or exhaustion related to cancer or cancer treatment
that is not proportional to recent activity and interferes with
usual functioning.” Besides, CRF has a severe impact on
daily activities, social relationships, reintegration, and overall
quality of life [6]. Some evidence has postulated that CRFmay
be considered as a predictor of survival for these patients [7].
Recent systematic reviews have shown that supervised
exercise has the power to combat many of the side effects
of cancer treatment and, thus, can be of significant benefit
to patients in the short and long term [8–11]. A recent
Cochrane systematic review on supervised multimodal exer-
cise and CRF [11] concluded that exercise can be considered
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as a beneficial intervention for individuals with CRF and
encouraged further research in this field. Benefits include
improved muscle strength and body composition in patients
with cancer [8, 12, 13]. The effects of multimodal exercise
have been attributed to improvements in adherence and
intensity [14], perhaps because of greater encouragement
or confidence to work when health professional help is at
hand. Therefore, it has been suggested that exercise must be
individualized to specific conditions of cancer survivors to
achieve the numerous benefits of exercise for the treatment
of cancer, such as prevention and symptoms management
[14, 15]; other authors reported that breast [16] and colon
[17] cancer survivors prefer supervised exercise training over
unsupervised exercise. In light of this, Lin et al. [18] compared
the effects of a supervised exercise intervention with those
of usual care for 12 weeks in colorectal cancer patients
during chemotherapy and found significant improvements
in the supervised exercise group on fatigue, physical activity
level, and physical functioning, social functioning, hand-
grip strength, cardiorespiratory fitness, and pain subscales of
quality of life (QoL). The authors concluded that supervised
exercise interventions result in larger benefits for cancer
patients on these outcomes when compared with usual
care. Likewise, Schneider et al. [15] reported that moderate
intensity individualized exercise improves cardiopulmonary
function and fatigue during and after treatment in a sample of
113 breast cancer patients. In a past review, Velthuis et al. [14]
addressed a subgroup analysis of supervised exercise only,
but they integrated this analysis within diagnosis groups,
thus limiting the power of their conclusions. The current
systematic review aims to update this growing evidence
adding specific analyses regarding the effects of supervised
multimodal exercise on CRF in cancer survivors.
2. Methods
2.1. Design. This systematic review is reported according to
the PRISMAStatement [19].We also followed the recommen-
dations described in the Cochrane Handbook for Systematic
Reviews of Interventions version 5.1.0 [20].
2.2. Literature Search. PubMed, CENTRAL, EMBASE, and
OVID databases were searched between January and March
2014 independently by two blinded authors (JFM-E and
RR-V). Search strategy incorporated the recommendations
for a highly sensitive search strategy for the retrieval of
clinical trials on PubMed [21]. The title and abstract were
examined and full text was obtained if there was ambiguity
regarding eligibility. The final search strategy was as follows:
(randomized controlled trial) OR controlled clinical trial)
OR randomized) OR trial) OR “clinical trials as topic”)
AND cancer) OR neoplasm∗) OR tumour∗) OR tumor∗)
OR carcino∗) OR leukaemi∗) OR leukemi∗) AND physical
activity) OR exercise) OR resistance) OR strength) OR
stretching) AND fatigue). In addition, the authors checked
the reference lists of the identified studies and the meeting
abstracts of the American Society of Clinical Oncology
(ASCO) Annual Meeting on its website from 2004 to 2013, as
well as certain journals (i.e., The Lancet Oncology, Journal of
Clinical Oncology, Journal of the National Cancer Institute,
Journal of Breast Cancer,The Breast Journal, andThe Breast).
No language restrictionswere applied.Attemptsweremade to
contact authors of trial reports if clarification was necessary.
See the Appendix for further details of the search strategy
procedures.
3. Selection Criteria
Selection criteria were built based on the PICO acronym as
follows.
3.1. Participants. This systematic review included studies
with patients (age > 18 years) diagnosed with any type of
cancer regardless of the stage of diagnosis or treatment.There
were no restrictions for sex, ethnicity, or race.
3.2. Intervention. The experimental intervention was multi-
modal exercise including aerobic, resistance, and stretching
exercise, whilst the control intervention was conventional
care, where patients did not participate in any exercise
intervention program. In this sense, resistance training (RT)
interventions were considered as any form of physical activity
that is designed to improve muscular fitness by exercising a
muscle or a muscle group against external resistance, per-
formed in a systematic manner in terms of frequency, inten-
sity, and duration, and is designed to maintain or enhance
health-related outcomes [22]. All interventions had to be
supervised by health professionals; therefore, home-based
programs, telephonemonitoring interventions, and cognitive
approaches were excluded. Yoga and tai-chi interventions
were not included because, although these interventions can
be supervised by healthcare providers, they do not exert a
large physiological impact (energy expenditure).
3.3. Outcome Measures. Primary outcome measure was CRF
symptoms measured using the Functional Assessment of
Cancer Therapy- (FACT-) Fatigue Scale, European Orga-
nization for Research and Treatment of Cancer Quality
of Life Questionnaire (EORTC QLQ-C30), Piper Fatigue
Scale (PFS), Schwartz Cancer Fatigue Scale (SCFS), and the
Multidimensional Fatigue Inventory (MFI).
Selection criteria were verified independently by two
blinded authors (JFM-E and RR-V) and disagreements were
solved through consensus and active participation of a third
author (EG-J).
3.4. Assessment of the Risk of Bias andMethodological Quality.
The methodological quality and risk of bias of the studies
were assessed using the Physiotherapy Evidence Database
(PEDro) scale [23]. The PEDro scale scores the method-
ological quality of randomized controlled studies out of 10.
Scores were based on all information available both from the
published version and from communicationwith the authors.
A score of 5 of 10 was set as the minimum score for inclusion
in the current meta-analysis. Publication bias was evaluated
through visual appraisal of the funnel plot built for CRF and
by Egger’s test (𝑃 < 0.05). Risk of bias was evaluated by two
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independent authors (JFM-E and EGJ) and a third author
mediated for consensus (RR-V). Interrater reliability between
authors was determined by calculating Cohen’s kappa.
3.5. Data Extraction and Analysis. Key characteristics of
the identified studies were also extracted including authors’
information, publication year, study design, cancer treat-
ment, time since diagnosis, and characteristics of the mul-
timodal exercise interventions (mode of training, length,
duration, and frequency) and effect estimates.Data extraction
was conducted independently by two authors (JFM-E and
RR-V) using a standard form; a third author (EG-J) arbitrated
in cases of disagreement if necessary. Comprehensive Meta-
Analysis Version 2.0 was used for the analyses. Continuous
outcomes were pooled calculating standardized mean dif-
ferences (SMD) with 95% confidence intervals (CI). Statis-
tical heterogeneity was evaluated through visual appraisal
of the forest plots and using the 𝐼2 statistic, which was
defined using the following cut-off parameters: not important
heterogeneity, 0% to 40%; moderate heterogeneity, 30% to
60%; substantial heterogeneity, 50% to 90%; and considerable
heterogeneity, 75% to 100% [20]. In the presence of high
heterogeneity (𝐼2 > 50%), the pooled effects were calculated
by a random effects model reported in accordance with
the DerSimonian and Laird method, which considers both
within-study and between-study differences [20]. On the
contrary, when substantial heterogeneity was not detected,
we conducted a fixed-effects model reported by using the
inverse variance method [20]. We performed a metaregres-
sion analysis to explore the predictor effects of the supervised
multimodal exercise characteristics, such as length (weeks),
frequency (sessions per week), and duration (minutes per
session), on the effect estimates. Subgroup analysis was
undertaken according to the stage of anticancer treatment
(active or not where reported) and by the mode of exercise
training. Publication bias was evaluated with Egger’s test and
a funnel plot [20]. All 𝑃 values were two-sided and were
considered significant at the 0.05 level.
4. Results
4.1. Characteristics of the Included Studies. A total of nine
randomized controlled trials (𝑛 = 772) were included [24–
32] (Figure 1). The assessment of risk of bias showed a mean
score of 6.4 (SD ± 1), indicating a low risk of bias and a
consistent methodological quality in the studies included
(Table 1). Interrater reliability between the two authors was
high (mean kappa = 0.81).
CRF levels were measured using the Functional Assess-
ment of Cancer Therapy- (FACT-) Fatigue Scale (FS) in
54.5% of the studies included, the European Organization for
Research and Treatment of Cancer Quality of Life Question-
naire (EORTC QLQ-C30; 30 items) in 36.3% of the studies,
the Piper Fatigue Scale (PFS) in 9.0% of the studies, and the
Schwartz Cancer Fatigue Scale (SCFS) in 9.0% of the studies
included.
4.2. Characteristics of Cancer Survivors. The mean age of
the cancer survivors ranged from 46 to 60 years with a
mean of 55.5 (SD ± 7.2) years. Most cancer survivors were
female (𝑛 = 419; 54.2%). Regarding cancer treatment stage,
most studies were performed during current treatment [24,
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Ergun et al. 2013
Milne et al. 2008
Mutrie et al. 2007
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Figure 2: Effect estimate of supervised multimodal exercise on CRF. Standardized mean difference (SMD) was calculated for the random
effects model of meta-analysis. IV, inverse of variance; CI, confidence interval.
25, 28–31]; the most common treatment was chemotherapy
(𝑛 = 522). The average number of months since cancer
diagnosis was 8.2 (SD ± 10.7), although this report was not
consistent across the studies included. Breast cancer was the
most investigated cancer type (𝑛 = 6) [25–30, 32], followed
by prostate cancer (𝑛 = 2) [28, 31], and one trial included
diverse types of cancer [24]. Time since diagnosis was not
consistently reported by authors, althoughmost of the studies
recruited women who were beyond five years since primary
cancer diagnosis. Table 2 summarizes the characteristics of
the studies included.
4.3. Characteristics of Supervised Multimodal Exercise Inter-
ventions. Multimodal exercise interventions had a mean
duration of 16.5 (SD ± 12.3) weeks with an average of 3 (SD ±
1.2) sessions per week. The mean session duration was 45
minutes (SD ± 29.1min). These interventions usually started
with aerobic training using stationary bicycle/cycle ergome-
ter, walking periods followed by strengthening exercises of
the upper limbs, and a final set of cooldown stretching exer-
cises. Training intensity varied considerably among studies,
ranging from 50% to 90% maximum heart rate. All studies
reported preexercise screening before exercise (Table 2).
4.4. Follow-Up in the Studies Included. Two studies commu-
nicated follow-up for their outcome measures. Milne et al.
[29] obtained data for follow-up from 97% of the participants
with an adherence rate of 61.3%; the authors reported a
significant increase in QoL, fatigue, anxiety, and physical
fitness at 12 and 24 weeks of their follow-up period. Mutrie
et al. [30] stated that the benefits in CRF observed from the
exercise group continued until 6 months of follow-up.
4.5. Adverse Events among Studies. Two studies [26, 31]
reported adverse events related to multimodal exercise inter-
ventions. Cantarero-Villanueva et al. [26] reported discom-
fort or low-intensity pain/stiffness in 3 patients; however,
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Figure 3: Funnel plot for the assessment of publication bias.
Fong et al. [33] reported three adverse events where one
case resulted in hospitalization or disability, one participant
referred to chest pain related to exercise with negative
cardiologic results, and in the aerobic group there was a case
of syncope without complications.
4.6. Pooled Analysis. Nine studies reported appropriate sta-
tistical measures for the meta-analysis [24–32]. Supervised
multimodal exercise interventions resulted in an overall
reduction in fatigue in cancer survivors (SMD = −0.23;
95% CI −0.37 to −0.09), 𝑃 = 0.001 with low statistical
heterogeneity (𝐼2 = 46.7%) (Figure 2).
4.7. Publication Bias. Visual appraisal of the funnel plot
showed slight evidence of publication bias, although the
reduced number of studies included could limit this analysis
(Figure 3) confirmed by Egger’s test (𝑃 = 0.04).
4.8. Subgroup Analyses: Stage of Treatment and Mode of
Exercise. Six randomized controlled trials involved cancer
patients undergoing active treatment; chemotherapy was the
most common regimen [24, 25, 28–31]. The pooled effects
showed overall significant improvements in CRF among
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Figure 4: Effect estimate of supervised multimodal exercise on CRF according to anticancer treatment stage. Standardized mean difference
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Figure 5: Effect estimate of supervised multimodal exercise on CRF according to the mode of exercise. A + RT + ST, aerobic exercise +
resistance training + stretching; RT, resistance training. Standardized mean difference (SMD) was calculated for the random effects model of
meta-analysis. IV, inverse of variance; CI, confidence interval.
cancer patients receiving anticancer treatment (SMD=−0.23,
95% CI −0.39 to −0.07), 𝑃 < 0.0001 with moderate statistical
heterogeneity (𝐼2 = 64%). Nonsignificant differences were
found after anticancer treatment (𝑃 = 0.10) (Figure 4).
With regard to mode of exercise, multimodal exercise
interventions including aerobic exercise + resistance training
+ stretching were implemented by seven studies [24–30]; the
pooled effect estimate for this subgroup showed significant
reductions in CRF symptoms (SMD = −0.35, 95% CI −0.62
to −0.08), 𝑃 = 0.01. Two studies evaluated the effects of
resistance training on CRF [31, 32]. The pooled effects were
not statistically significant (SMD = −0.17, 95% CI −0.50 to
0.15), 𝑃 = 0.30 (Figure 5).
4.9. Metaregression: Heterogeneity and Dose-Response Rela-
tionships. Our metaregression model showed that length
(weeks of training), frequency (sessions/week), and duration
(minutes/session) of the supervised multimodal exercise
interventions were lineally associated with overall improve-
ments in CRF levels (Tau-squared = 0.04, 𝑃 = 0.04)
(Figure 6). No significant dose-response interactions were
observed for publication year and training intensity (𝑃 >
0.05).























































Figure 6: Bubble plot for the dose-response relationship between
the intervention duration (minutes/session) and effect estimates
changes for CRF from the nine randomized controlled trials
included in the metaregression analysis (𝑃 = 0.04).
5. Discussion
Our pooled analysis demonstrated that supervised multi-
modal exercise improves CRF when compared with con-
ventional care. Similar results have been presented in prior
10 BioMed Research International
meta-analyses on fatigue symptoms [8, 14], depression [34],
and QoL [35] in cancer survivors. Further, our results are
in line with those published by Fong et al. [33], where
physical activity including strengthening exercises, with or
without supervision, was positively associated with body
composition, physical functioning, and psychological out-
comes including fatigue. Nevertheless, there is insufficient
information available to elucidate the physiological mecha-
nisms for the effects of supervised multimodal exercise in
reducing fatigue during cancer therapy and further research
is warranted in this field [36–40].
Different from other systematic reviews, a novel finding
of this review is that most interventions included in this
meta-analysis were performed during an active treatment
stage, especially chemotherapy. In this sense, recent findings
published by Oechsle et al. [41] in a prospective randomized
pilot trial found that structured exercise improved CRF
in 48 patients receiving myeloablative chemotherapy who
received supervised exercise five times a week with ergometer
training and strength exercises for 20min each during the
hospitalization period. Our results and the current body of
evidence demonstrate that RT and exercise interventions
can provide significant effects on fatigue during cancer
treatment, especially in patients receiving chemotherapy;
however, further trials are needed to reinforce this evidence
and encourage structured exercise interventions for cancer
survivors undergoing anticancer treatment.
In this sense, the present meta-analysis revealed that
supervised multimodal exercise leads to a significant reduc-
tion in fatigue scores in cancer survivors during and after
cancer treatment. The effects of RT were not addressed by
the American Cancer Society [3] that recommended RT
but have been recently examined in patients undergoing
cancer treatment [42]. Nevertheless, further studies are
needed before RT can be recommended for cancer patients
undergoing cancer therapy. Specifically, more information is
required regarding the effects of initial chemotherapy and
radiation therapy on muscle satellite (progenitor) cells that
proliferate in response to supervised multimodal exercise [8,
42]. Clinically, this may allow the maintenance or an increase
in functional performance, as well as a reduction of the risk
of developing CRF, and improve perceived energy, mental
capacity, and psychological status. It is not clear whether
previously sedentary patients can or will adhere to an exercise
program as proposed by ACSM and, if they cannot, whether
the amount of exercise they do engage inwill still be of benefit
in terms of symptom relief (i.e., anxiety, depression, lack of
sleep, and mood change) and reduction of the risk of adverse
events [43].
In light of this evidence and considering that supervised
exercise is broadly accepted as a beneficial intervention for
cancer survivors, it is necessary to carefully conduct pre-
screening procedures for cancer survivors in order to achieve
an adequate prescription of exercise programs, adjusting
patient’s specific variables, such as physiological responses
and physical disturbances underlying carcinogenic process
and its treatment [38]. Thus, healthcare providers who have
knowledge of exercise prescription in cancer patients are
ideally placed to pursue further research in this area and
to prescribe physical exercise among cancer survivors [43–
46]. Our findings indicate that health professionals must
recognize the important benefits of adjuvant interventions
in cancer survivors, such as exercise, that counteract the
negative side effects of cancer treatments.
Naturally, our study has some limitations that need to be
addressed. First, the average score of the quality of the studies
included in this is greater than the average score for trials in
physiotherapy. The risk of bias was evaluated by one author
and this could be a limitation for this process, although this
limitation could be counteracted considering that PEDro
scale is a broadly validated tool. A second limitation is that
considerable statistical heterogeneity was present in all effect
estimates. Possible explanations for this heterogeneity are the
diversity of sample sizes, the characteristics of strengthening
programs (i.e., length, duration, and intensity) evaluated
in the studies included, and the wide variety in outcome
measurement tools used among studies. This heterogeneity
can be observed in the forest plots (Figures 2–4).
6. Conclusion
In summary, the findings of this systematic review can be
used to promote professional supervision in cancer rehabil-
itation settings and, eventually, to reinforce the conception
that supervised exercise is safe and beneficial for cancer
survivors through amajor recommendation of strengthening
programs by health professionals. A broader recommen-
dation of exercise will lead to achievement of consistent
weekly volumes of exercise if possible, including exercise
twice weekly, and stretching exercises on days of nonexercise.
Likewise, these results supported the implementation of
personalized supervision in research, since it can optimize
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